Verified email-pattern data for Epynext Therapeutics is currently limited. You can still use the company insights and contact sections below.
Epynext Therapeutics is dedicated to the development of innovative immunotherapy to fight against antibiotic resistance, one of the most urgent health threats of our time particularly in hospital settings.
Epynext Therapeutics’ mission is to give inpatients infected with bacteria resistant to antibiotics an alternative therapy through targeted monodose treatments, in the form of neutralizing therapeutic monoclonal antibodies.
Epynext Therapeutics is leveraging an innovative technological platform developed by Pr Jean-Luc Lenormand ,from the TIMC laboratory in Grenoble.
This technological platform enables the production of therapeutic monoclonal antibodies directed against membrane antigens presented within liposomes through a cell-free protein synthesis system.
Such recombinant proteo-liposomes expose all the linear and conformational epitopes of the membrane antigen, as in the pathogen.
Resulting antibodies have a remarkably high affinity and specificity for their target opening the field for new applications against resistant bacteria, the first objective for Epynext Therapeutics, but also viruses or tumoral cells.
A first antibody targeting Pseudomonas aeruginosa strains multi-resistant to antibiotics has demonstrated its ability to inhibit Pa both in vitro and in vivo.
Originated within the University Grenoble-Alpes, Epynext Therapeutics has been supported by the SATT Linksium since 2017.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 31, Rue Gustave Eiffel, C/o Linksium,france
- Industry
- Biotechnology Research
- Keywords
- Imunotherapies, anti-infectives, Nosocomial infections, Monoclonal antibodies, Cell-free synthesis, Proteo-liposomes, biotechnology, Anti-Microbial Resistance.
- HQ
- Grenoble, Auvergne-Rhône-Alpes
Epynext Therapeutics Questions
Epynext Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/epynext-therapeutics
Epynext Therapeutics has
2 employees.
View email and phone details for 2
employees at Epynext Therapeutics.
Epynext Therapeutics's industry is
Biotechnology Research
Epynext Therapeutics's top competitors are
Alpioner Therapeutics,
The Element Biotechnology,
Synthelis,
Lxrepair 2013-2023,
Linksium,
Pulsalys,
Ais Biotech,
React Therapeutics,
Stromacare,
Meddenovo Drug Design.
Epynext Therapeutics's categories are Biotechnology Research
Epynext Therapeutics's founding year is 2022
Explore related pages
Related company profiles:
Companies like Epynext Therapeutics
Top Epynext Therapeutics Employees
-
Louis Farge
Ceo Epynext Therapeutics
Greater Paris Metropolitan Region, France, France1laposte.net -
Guillaume Lacroix
Directeur De Laboratoire/Ingénieur R&D Chez Epynext Therapeutics
Greater Grenoble Metropolitan Area, France
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.